Cargando…

SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment

Stratification of patients with pancreatic ductal adenocarcinoma (PDAC) remains a key challenge in the field of clinical oncology. No predictive biomarkers have yet been found for any available treatment options. Previously, we identified SERPINB7 as a putative biomarker for PDAC and thus, herein, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bianconi, Daniela, Herac, Merima, Spies, Daniel, Kieler, Markus, Brettner, Robert, Unseld, Matthias, Fürnkranz, Katrin, Famler, Barbara, Schmeidl, Margit, Minichsdorfer, Christoph, Zielinski, Christoph, Heller, Gerwin, Prager, Gerald W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2018
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149193/ https://www.ncbi.nlm.nih.gov/pubmed/30245304 http://dx.doi.org/10.1016/j.tranon.2018.08.019

Ejemplares similares

Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC
por: Bianconi, Daniela, et al.
Publicado: (2020)

Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel
por: Bianconi, Daniela, et al.
Publicado: (2017)

Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior
por: Bianconi, Daniela, et al.
Publicado: (2022)

Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer
por: Bartl, Thomas, et al.
Publicado: (2023)

Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer Patients
por: Unseld, Matthias, et al.
Publicado: (2020)

Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer
por: Kieler, Markus, et al.
Publicado: (2017)

A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid
por: Kieler, Markus, et al.
Publicado: (2019)

Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy
por: Kieler, Markus, et al.
Publicado: (2018)

Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients
por: Kieler, Markus, et al.
Publicado: (2020)

Feasibility of personalized treatment concepts in gastrointestinal malignancies: Sub-group results of prospective clinical phase II trial EXACT
por: Unseld, Matthias, et al.
Publicado: (2018)

Bead-Based Isolation of Circulating Tumor DNA from Pancreatic Cancer Patients Enables High Fidelity Next Generation Sequencing
por: Balendran-Braun, Sukirthini, et al.
Publicado: (2021)

Integrins in the Spotlight of Cancer
por: Bianconi, Daniela, et al.
Publicado: (2016)

Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI
por: Kieler, Markus, et al.
Publicado: (2019)

CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior
por: Poettler, Marina, et al.
Publicado: (2013)

SerpinB2 is involved in cellular response upon UV irradiation
por: Majoros, Hajnalka, et al.
Publicado: (2019)

Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology
por: Prager, Gerald W., et al.
Publicado: (2019)

Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky disease
por: Kieler, Markus, et al.
Publicado: (2016)

Recurrent SERPINB3 and SERPINB4 Mutations in Patients that Respond to Anti-CTLA4 Immunotherapy
por: Riaz, Nadeem, et al.
Publicado: (2016)

Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer
por: Prager, Gerald W, et al.
Publicado: (2014)

IgM-Linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease
por: Biasiolo, Alessandra, et al.
Publicado: (2012)

Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition
por: Biasiolo, Alessandra, et al.
Publicado: (2023)

SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma
por: Willmes, Christoph, et al.
Publicado: (2016)

Liver pro-oncogenic potential of SERPINB3
por: Pontisso, Patrizia, et al.
Publicado: (2014)

Serpinb1a suppresses osteoclast formation
por: Ishida, Masayoshi, et al.
Publicado: (2021)

Induction of SerpinB2 and Th1/Th2 Modulation by SerpinB2 during Lentiviral Infections In Vivo
por: Major, Lee D., et al.
Publicado: (2013)

The Role of EREG, PTPN1, and SERPINB7 Genes in the Pathogenesis of Psoriasis: May SERPINB7 Be Protective and a Marker of Severity for Psoriasis?
por: Ayvaz, Havva Hilal, et al.
Publicado: (2022)

SERPINB3 is associated with longer survival in transgenic mice
por: Villano, Gianmarco, et al.
Publicado: (2013)

Hepatic progenitor cells express SerpinB3
por: Villano, Gianmarco, et al.
Publicado: (2014)

Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH
por: Bruschi, Francesca V., et al.
Publicado: (2020)

Transcriptome analysis of SerpinB2-deficient breast tumors provides insight into deciphering SerpinB2-mediated roles in breast cancer progression
por: Piao, Yin Ji, et al.
Publicado: (2022)

Statins induce apoptosis in human melanoma cells via multiple pathways
por: Minichsdorfer, Christoph, et al.
Publicado: (2008)

Cytokine signalling in human melanoma cells determines susceptability to statin-induced apoptosis
por: Minichsdorfer, Christoph, et al.
Publicado: (2009)

CORRIGENDUM: SERPINB3 is associated with longer survival in transgenic mice
por: Villano, Gianmarco, et al.
Publicado: (2014)

SERPINB2 is a novel indicator of stem cell toxicity
por: Lee, Na-Hee, et al.
Publicado: (2018)

SERPINB3, Adult-Onset Immunodeficiency, and Generalized Pustular Psoriasis
por: Kantaputra, Piranit, et al.
Publicado: (2023)

SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity
por: Turato, Cristian, et al.
Publicado: (2015)

Nagashima-Type Palmoplantar Keratosis with Compound Heterozygous Mutations in SERPINB7
por: Songsantiphap, Chankiat, et al.
Publicado: (2020)

SerpinB3 drives cancer stem cell survival in glioblastoma
por: Lauko, Adam, et al.
Publicado: (2022)

SerpinB3 as hepatic marker of post-resective shear stress
por: Gringeri, Enrico, et al.
Publicado: (2023)

DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancers
por: Heller, Gerwin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8g66fet5d7h4k62254cp6n47t6